Pipenzolate bromide

Summary

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1]

Pipenzolate bromide
Clinical data
ATC code
Identifiers
  • 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide
CAS Number
  • 125-51-9 checkY
PubChem CID
  • 657306
ChemSpider
  • 571430 ☒N
UNII
  • JPX41DUS2B
ChEMBL
  • ChEMBL1401367 ☒N
CompTox Dashboard (EPA)
  • DTXSID2023480 Edit this at Wikidata
ECHA InfoCard100.004.311 Edit this at Wikidata
Chemical and physical data
FormulaC22H28BrNO3
Molar mass434.374 g·mol−1
3D model (JSmol)
  • Interactive image
  • CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-]
  • InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ☒N
  • Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ☒N
 ☒NcheckY (what is this?)  (verify)

Mechanism of action edit

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]

References edit

  1. ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.